Viewing Study NCT00786006


Ignite Creation Date: 2025-12-26 @ 10:59 AM
Ignite Modification Date: 2026-01-01 @ 1:32 AM
Study NCT ID: NCT00786006
Status: COMPLETED
Last Update Posted: 2011-12-06
First Post: 2008-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Randomized Phase II Study of FOLFOX Versus FOLFIRI.3 in Gemcitabine-refractory Pancreatic Cancer
Sponsor: Asan Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module